Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DZ5K6F
|
|||
| Drug Name |
GB1275
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10; ICD-9: 157] | Phase 1/2 | [1] | |
| Company |
Gossamer Bio
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Integrin alpha-M (ITGAM) | Target Info | Agonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04060342) GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma. U.S. National Institutes of Health. | |||
| REF 2 | National Cancer Institute Drug Dictionary (drug name GB1275). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.